Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study

Shaoke Meng,1,&ast; Lei Guo,1,&ast; Zhishuai Ye,2 Junjie Wang,1 Huaiyu Ding,1 Shanshan Wu,3 Rongchong Huang2 1Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian City, People’s Republic of China; 2Cardiac Center/Division of Cardiovascular Diseases, Be...

Full description

Bibliographic Details
Published in:	Clinical Interventions in Aging
Main Authors:	Meng S, Guo L, Ye Z, Wang J, Ding H, Wu S, Huang R
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-04-01
Subjects:	ticagrelor elderly percutaneous coronary intervention dual antiplatelet therapy
Online Access:	https://www.dovepress.com/comparison-of-clinical-outcomes-between-ticagrelor-and-clopidogrel-in--peer-reviewed-fulltext-article-CIA

Similar Items

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
by: Jialun Han, et al.
Published: (2023-03-01)

In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention
by: Aaron E. Brice, et al.
Published: (2017-04-01)

Breaking boundaries: Ticagrelor monotherapy in high-risk patients
by: Balbir Singh, et al.
Published: (2024-12-01)

Efficacy and safety of switching from ticagrelor to clopidogrel during the early and late phase in acute coronary syndrome patients after percutaneous coronary intervention
by: Chenggang Wang, et al.
Published: (2020-04-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study
by: Salman Nikfarjam, et al.
Published: (2023-01-01)

Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials
by: Chen Ning, et al.
Published: (2024-03-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Yue Wang, et al.
Published: (2022-02-01)

Comparison of clopidogrel and ticagrelor in treating acute coronary syndrome undergoing PCI: A systematic review and meta-analysis
by: Jing Yang, et al.
Published: (2024-03-01)

Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention
by: Dunya Habeeb Shnain, et al.
Published: (2024-06-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry
by: Ziwei Xi, et al.
Published: (2022-11-01)

Effectiveness of clopidogrel vs. ticagrelor based on the ABCD-GENE score in acute coronary syndrome patients following percutaneous coronary intervention
by: Xiaotong Xu, et al.
Published: (2025-06-01)

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
by: Tienan Zhou, et al.
Published: (2023-03-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis
by: Liyuan Wang, et al.
Published: (2025-05-01)

Sex-based outcomes on unguided de-escalation from ticagrelor to clopidogrel in stabilized patients with acute myocardial infarction undergoing percutaneous coronary intervention: a post-hoc analysis of the TALOS-AMI
by: Eun-Seok Shin, et al.
Published: (2024-03-01)

Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy
by: Barry W. Hennigan, et al.
Published: (2022-01-01)

Effect of ticagrelor versus clopidogrel after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome—propensity score matching analysis
by: Yinan Zhao, et al.
Published: (2024-01-01)

Adherence of ticagrelOr in real world patients with aCute coronary syndrome: The AD-HOC study
by: Luigi Fiocca, et al.
Published: (2022-10-01)

Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta‐Analysis
by: Waqas Ullah, et al.
Published: (2024-10-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01)

Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation
by: Ana Lucrecia Marcano, et al.
Published: (2022-11-01)

Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention
by: Pei Zhu, et al.
Published: (2019-10-01)

Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: A systematic review and network meta‐analysis
by: Yuttana Wongsalap, et al.
Published: (2023-12-01)

Ticagrelor effectively inhibits platelet aggregation in comatose survivors of cardiac arrest undergoing primary percutaneous coronary intervention treated with mild therapeutic hypothermia
by: Marek T. Tomala, et al.
Published: (2023-08-01)

Effect of ticagrelor combined with metoprolol extended-release tablets on cardiac function and clinical prognosis in elderly patients with acute coronary syndrome after percutaneous coronary intervention
by: Lili Wang, et al.
Published: (2025-01-01)

Efficacy and safety of clopidogrel and ticagrelor in acute coronary syndrome patients with CYP2C19 loss-of-function alleles after percutaneous coronary intervention: based on the Global Registry of Acute Coronary Events score
by: Dan Dang, et al.
Published: (2025-08-01)

Ticagrelor in patients with stable coronary artery disease: a role in improving prognosis
by: T. N. Novikova
Published: (2020-09-01)

Ticagrelor versus clopidogrel after intracranial stent angioplasty: a real-world study
by: Lili Sun, et al.
Published: (2023-08-01)

Absolute thrombocytopenia with ticagrelor
by: Awatif Hafiz, et al.
Published: (2024-01-01)

Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
by: Byung Gyu Kim, et al.
Published: (2023-03-01)

Antiplatelet Therapy in Chronic Coronary Artery Disease Patients With a History of Angioplasty. When is Aspirin Not Enough? A Systematic Review
by: Stylianos Fiflis, et al.
Published: (2025-09-01)

Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry
by: Chunfeng Dai, et al.
Published: (2024-04-01)

Clinical Characteristics and Outcomes of Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study
by: Ahmed Hassan, et al.
Published: (2024-12-01)